All News | RheumNow

All News

Best of 2020: The COVID-19 Global Rheumatology Registry

Save

d Kathryn H. Dao, M.D.

Dec 24, 2020

What started out as online tweets and sharing newsfeed and case reports, has progressed to the formation of the COVID-19 Global Rheumatology Alliance, whose mission is to create an international rheumatology registry of patients affected by the disease in order to better understand the disease and guide clinicians in assessing and treating patients.

Read Article

Best of 2020: A Rheumatologist’s Tips: Telemedicine in 6 Easy Steps

Save

d Kathryn H. Dao, M.D.

Dec 23, 2020

Ready for telemedicine/telerheumatology?

Once you and your patient agree on a virtual visit, the following suggestions may help facilitate the interaction. If you have the ability and the capacity, record the visit.

Read Article

Corona.COVID_.jpg

Best of 2020: Rheumatic Disease Drugs and COVID-19

Save

d Jack Cush, MD

Dec 22, 2020

We are in the early stages of trying to limit the morbid and mortal consequences of the corona virus pandemic of 2020. Not surprisingly, the recommendations designed to limit exposure and damage continually highlight the fact that the elderly and immunosuppressed may be amongst the most severely affected should they become infected with this virus.

This has led to a great deal of uncertainty by patients and providers about how rheumatic diseases and their treatments need to be specifically addressed.

Read Article

#BestACR20Tweets RT @KDAO2011 : #ACR20 Abstr#0431 Hydroxychloroquine Use Was Not Associated with QTc Length in a Large Cohort of SLE and RA Patients @rheumnow https://t.co/7yn0fK1tfn

Links:

https://bit.ly/3hhGH2h

Dr. John Cush RheumNow ( View Tweet)

Dec 24, 2020

#BestACR20Tweets RT @uptoTate : Claims-based "big data" reveals PsA pts had "arthritis" coding prior to formal dx and coding for enthesitis, axial dz, and arthritis increased prior to PsA dx. Coding diff between treating specialties also noted. #ACR20 https://t.co/naeRPFZdap https://t.co/E4XvlZSsX6

Links:

https://bit.ly/37KhPNC

Dr. John Cush RheumNow ( View Tweet)

Dec 24, 2020

Content Download Available! Download our document on arthritis myths below. https://t.co/2Kxpou4Fbz https://t.co/iPIqR92ME1

Links:

https://bit.ly/2KzYdD0

Dr. John Cush RheumNow ( View Tweet)

Dec 23, 2020

#Bestof2020: A Rheumatologist’s Tips: Telemedicine in 6 Easy Steps https://t.co/p8B0dDTktT https://t.co/sHBisreYnW

Links:

https://bit.ly/37HohFd

Dr. John Cush RheumNow ( View Tweet)

Dec 23, 2020

#Bestof2020: Rheumatic Disease Drugs and COVID-19 https://t.co/82uGbNqm9R https://t.co/U0WyTL5kYZ

Links:

https://bit.ly/34EX1W6

Dr. John Cush RheumNow ( View Tweet)

Dec 23, 2020

#ACR20 Mid Meeting Recap: Gout https://t.co/MhaYjotrmb https://t.co/R4dOrSlFl6

Links:

https://bit.ly/3pgR35E

Dr. John Cush RheumNow ( View Tweet)

Dec 23, 2020

#BestACR20Tweets RT @uptoTate :Dactylitis is a clinical indicator for an aggressive phenotype of PsA categorized w/ significantly greater TJC, SJC, CRP, US synovitis/erosions in very early DMARD naïve pts. #ABS0312 #ACR20 https://t.co/d2ZjXRgvkE https://t.co/60n5pNfx9O https://t.co/EvsR0aJtXJ

Links:

Dr. John Cush RheumNow ( View Tweet)

Dec 23, 2020

#BestACR20Tweets RT @RichardPAConway : Dr Fernandez-Diaz on abatacept in RA-ILD in 263 patients. Abatacept appears safe and effective. Equivalent to RTX. Good option as s/c admin @rheumnow #ACR20 Abstr#0233 #ACRbest https://t.co/yqV6BoKy4s https://t.co/7jUASw5D2f

Links:

https://bit.ly/3h7hLum

Dr. John Cush RheumNow ( View Tweet)

Dec 23, 2020

Make sure you check out the RheumNow podcast on Soundcloud or Apple/Android devices. New episodes every week! https://t.co/wjBWCrKL34 https://t.co/3z2aWfB95V

Links:

https://bit.ly/3pjQqJ2

Dr. John Cush RheumNow ( View Tweet)

Dec 23, 2020

#Bestof2020 Goodwill Wednesday https://t.co/2mJ0xJNChL https://t.co/5SP90IVpwg

Links:

https://bit.ly/3nSZUKx

Dr. John Cush RheumNow ( View Tweet)

Dec 22, 2020

#BestACR20Tweets RT @RichardPAConway : Really important study by @SattuiSEMD on high prevalence of frailty and its impact on QOL in PMR #ACR20 @rheumnow Abstr#422 https://t.co/QzDYGsqDeJ

Dr. John Cush RheumNow ( View Tweet)

Dec 22, 2020

Autoinflammatory & Still's Disease Panel #acr20 Dr. Jack Cush leads a panel of experts regarding Still's Disease and ACR 2020. https://t.co/4GmM56l1cb https://t.co/WbXMUtz6Up

Links:

https://bit.ly/3h8CIoG

Dr. John Cush RheumNow ( View Tweet)

Dec 22, 2020

#BestACR20Tweets RT @bella_mehta : Another addition to - where you live matters! #EosinophilicFasciitis regional clustering seen in proximity to ash, landfills, chemical release sites, and combustion facilities + clustering seen in low SES and minority communities #ACR20 https://t.co/VSMYIO7EuX

Dr. John Cush RheumNow ( View Tweet)

Dec 22, 2020

Psoriatic Arthritis Panel Discussion Drs. Artie Kavanaugh, Jack Cush, Eric Ruderman and Alexis Ogdie-Beatty discuss novel issues and new drug studies from #ACR20. https://t.co/KLEBuWNHkn https://t.co/ERIT7f9rNq

Links:

https://bit.ly/3rfXurg

Dr. John Cush RheumNow ( View Tweet)

Dec 22, 2020

#Bestof2020 The Nine Lives of Hydroxychloroquine https://t.co/pDmAEXg7QH https://t.co/d7qG7DmCL9

Links:

https://bit.ly/3azADRA

Dr. John Cush RheumNow ( View Tweet)

Dec 22, 2020

#BestACR20Tweets RT @jeffsparks :Important results from @kmdsilvaMD (newly funded by @RheumResearch): rheumatic patients with COVID with higher risk of hospitalization, ICU admission, CHF, AKI, and VTE than matched comparators. @zach_wallace_md https://t.co/bmuPBf89xD https://t.co/njHYkbenjy

Links:

https://bit.ly/34ywAkJ

Dr. John Cush RheumNow ( View Tweet)

Dec 22, 2020

Exclusive interview with Dr. David Karp, 84th ACR president #ACR20 Dr. Kathryn Dao ( @KDAO2011) interviews the man who inspired her to become a rheumatologist. https://t.co/v7B0OYVOAo https://t.co/UNM2xU1mbM

Links:

https://bit.ly/38o1JZ3

Dr. John Cush RheumNow ( View Tweet)

Dec 21, 2020

×